Search Results

FDA Approves Susvimo for Diabetic Macular Edema.

• Authors : Myshko, Denise

Subjects: INTRAVITREAL injections; DIABETIC retinopathy; UNITED States. Food & Drug AdministrationUNITED States

• Source: Formulary Watch. 2/5/2025, p1-2. 2p.

Record details

ASRS abroad: Retina specialists converge in Sweden.

• Authors : Hayes, Hattie

• Source: Ophthalmology Times Europe. Jul/Aug2024, Vol. 20 Issue 6, p32-34. 3p.

Record details

CASE REPORT: Refractory pseudophakic cystoid macular edema during an exacerbation of scleroderma.

• Authors : Barbour, Monique M.; George, Bria

• Source: Optometry Times. May2023, Vol. 15 Issue 5, p13-17. 3p.

Record details

3 Things You Should Know About Optimizing Retinal Disease Treatment.

Subjects: DIABETES complications; CONTINUING education units; OPHTHALMOLOGISTS

• Source: Ophthalmology Times. Jan/Feb2025, Vol. 50 Issue 1, p53-55. 3p.

Record details

Things You Should Know About Diagnosing and Managing Uveitic Macular Edema.

• Authors : Yeh, Steven¹

• Source: Ophthalmology Times. May2022, Vol. 47 Issue 5, p37-39. 3p.

Record details

3 Things You Should Know About Diabetic Macular Edema.

• Authors : Khanani, Arshad M.^1,2

• Source: Ophthalmology Times. Apr2022, Vol. 47 Issue 4, p48-50. 3p.

Record details

3 Things You Should Know About Uveitic Macular Edema.

• Authors : Yeh, Steven^1,2

• Source: Ophthalmology Times. Feb2022, Vol. 47 Issue 2, p45-47. 3p.

Record details

CONTINUING MEDICAL EDUCATION. 3 Things You Should Know About Newer Treatments for nAMD and DME.

• Authors : Talcott, Katherine E.¹

• Source: Ophthalmology Times. Feb2024, Vol. 49 Issue 2, p34-36. 3p.

Record details

FDA Accepts Alvotech/Teva's Application for Eylea Biosimilar.

• Authors : Myshko, Denise

Subjects: VASCULAR endothelial growth factors; RETINAL degeneration; DIABETIC retinopathy

• Source: Formulary Watch. 2/18/2025, p1-2. 2p.

Record details

Bausch + Lomb Launches Xipere for Macular Edema.

Subjects: MACULAR edema; OPTOMETRY; CONTACT lensesNEBRASKA

• Source: Formulary Watch. 3/28/2022, p1-2. 2p.

Record details